Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -3.50% | 2.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.50% | 2.35% | |||
| Cost of Revenue | 7.25% | -4.17% | |||
| Gross Profit | -5.81% | 3.86% | |||
| SG&A Expenses | 9.84% | -21.37% | |||
| Depreciation & Amortization | -1.22% | 0.06% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.12% | -11.32% | |||
| Operating Income | -15.39% | 26.41% | |||
| Income Before Tax | -26.37% | 7.28% | |||
| Income Tax Expenses | 69.60% | 86.04% | |||
| Earnings from Continuing Operations | -34.89% | -53.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -34.89% | -53.70% | |||
| EBIT | -15.39% | 26.41% | |||
| EBITDA | -12.12% | 23.13% | |||
| EPS Basic | -35.17% | -53.13% | |||
| Normalized Basic EPS | -20.60% | 2.37% | |||
| EPS Diluted | -37.50% | -52.57% | |||
| Normalized Diluted EPS | -20.76% | 2.33% | |||
| Average Basic Shares Outstanding | 0.46% | -1.23% | |||
| Average Diluted Shares Outstanding | 0.71% | -1.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||